Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
ANI Pharmaceuticals Inc - SIC # 2834 - PHARMACEUTICAL PREPARATIONS
Ticker
Exchange
SIC #
Website
Latest Ticker
ANIP
Nasdaq
2834
https://www.anipharmaceuticals.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for ANI Pharmaceuticals Inc
Moderna (MRNA) Posts Pipeline Progress, Secures Blackstone Funding
- Mar 28th, 2024 3:38 pm
ANI Pharmaceuticals (ANIP) Rises Yet Lags Behind Market: Some Facts Worth Knowing
- Mar 27th, 2024 10:15 pm
Praxis (PRAX) Surges on Positive Epilepsy Study Results
- Mar 27th, 2024 2:53 pm
ANI Pharmaceuticals Announces the Launch of Levofloxacin Oral Solution, USP
- Mar 27th, 2024 10:50 am
Axsome's (AXSM) Narcolepsy Drug Study Meets Primary Goal
- Mar 26th, 2024 3:24 pm
CHMP to Delay Nod on Biogen (BIIB), Eisai's Alzheimer's Drug
- Mar 26th, 2024 3:21 pm
ANI Pharmaceuticals, Inc. (ANIP) Hits Fresh High: Is There Still Room to Run?
- Mar 26th, 2024 1:15 pm
NYCB, Vista Outdoor, Cardlytics, and More Stocks See Action From Activist Investors
- Mar 23rd, 2024 1:54 am
Novo Nordisk (NVO) Gets Positive CHMP Opinion for Insulin Icodec
- Mar 22nd, 2024 3:53 pm
Merck's (MRK) Keytruda-Lynparza Combo Fails 2nd Lung Cancer Study
- Mar 22nd, 2024 2:26 pm
ANI Pharmaceuticals (ANIP) Outpaces Stock Market Gains: What You Should Know
- Mar 21st, 2024 10:00 pm
Lifecore (LFCR) Down 30% on Ending Strategic Review With No Deal
- Mar 21st, 2024 4:40 pm
ACELYRIN (SLRN) Up on Data From Thyroid Eye Disease Study
- Mar 21st, 2024 3:12 pm
Axsome (AXSM) Begins Dosing in Depression Study on Sunosi
- Mar 20th, 2024 4:12 pm
ANI (ANIP) Is Considered a Good Investment by Brokers: Is That True?
- Mar 20th, 2024 1:30 pm
ANI Pharmaceuticals (ANIP) Gains But Lags Market: What You Should Know
- Mar 19th, 2024 10:15 pm
Intellia (NTLA) Begins Dosing in Phase III ATTR Amyloidosis Study
- Mar 19th, 2024 5:06 pm
Cybin (CYBN) Begins Phase II Study on Anxiety Drug, Stock Up
- Mar 18th, 2024 3:23 pm
Immuneering (IMRX) Plummets 71% in One Week: Here's Why
- Mar 18th, 2024 3:02 pm
Allogene's (ALLO) Q4 Loss Narrower Than Expected, Sales Miss
- Mar 15th, 2024 1:32 pm
Scroll